Age of Onset and Lifetime Projected Risk of Psychotic Experiences: Cross-National Data from the World Mental Health Survey
-
2016/07/01
-
Details
-
Personal Author:Al-Hamzawi AO ; Alonso J ; Andrade L ; Borges G ; Bromet EJ ; Bruffaerts R ; Caldas de Almeida JM ; de Girolamo G ; de Jonge P ; Fayyad J ; Florescu S ; Gureje O ; Hu C ; Kendler KS ; Kessler RC ; Kovess-Masfety V ; Lim CCW ; McGrath JJ ; Navarro-Mateu F ; Oakley Browne M ; Piazza M ; Pierre Lepine J ; Posada-Villa J ; Saha S ; Sampson N
-
Description:Background: Given the early age of onset (AOO) of psychotic disorders, it has been assumed that psychotic experiences (PEs) would have a similar early AOO. The aims of this study were to describe (a) the AOO distribution of PEs, (b) the projected lifetime risk of PEs, and (c) the associations of PE AOO with selected PE features. Methods: Data came from the WHO World Mental Health (WMH) surveys. A total of 31,261 adult respondents across 18 countries were assessed for lifetime prevalence of PE. Projected lifetime risk (at age 75 years) was estimated using a 2-part actuarial method. AOO distributions were described for the observed and projected estimates. We examined associations of AOO with PE type metric and annualized PE frequency. Results: Projected lifetime risk for PEs was 7.8% (SE = 0.3), slightly higher than lifetime prevalence (5.8%, SE = 0.2). The median (interquartile range; IQR) AOO based on projected lifetime estimates was 26 (17-41) years, indicating that PEs commence across a wide age range. The AOO distributions for PEs did not differ by sex. Early AOO was positively associated with number of PE types (F = 14.1, P < .001) but negatively associated with annualized PE frequency rates (F = 8.0, P < .001). Discussion: While most people with lifetime PEs have first onsets in adolescence or young adulthood, projected estimates indicate that nearly a quarter of first onsets occur after age 40 years. The extent to which late onset PEs are associated with (a) late onset mental disorders or (b) declining cognitive and/or sensory function need further research. [Description provided by NIOSH]
-
Subjects:
-
Keywords:
-
ISSN:0586-7614
-
Document Type:
-
Funding:
-
Genre:
-
Place as Subject:
-
CIO:
-
Topic:
-
Location:
-
Volume:42
-
Issue:4
-
NIOSHTIC Number:nn:20049768
-
Citation:Schizophr Bull 2016 Jul; 42(4):933-941
-
Contact Point Address:Dr. John J. McGrath, Queensland Brain Institute, The University of Queensland, St Lucia, Queensland 4076, Australia
-
Email:j.mcgrath@uq.edu.au
-
Federal Fiscal Year:2016
-
Performing Organization:State University New York Stony Brook
-
Peer Reviewed:True
-
Start Date:20140701
-
Source Full Name:Schizophrenia Bulletin
-
End Date:20170630
-
Collection(s):
-
Main Document Checksum:urn:sha-512:b138d5e05eff6710dd09cddf92f4b47ebe38781454b1b544be6d1939af925d902ea8722abe2d70c0676f0b16471594b9b8d5c73554af42797385d475630be6c2
-
Download URL:
-
File Type:
ON THIS PAGE
CDC STACKS serves as an archival repository of CDC-published products including
scientific findings,
journal articles, guidelines, recommendations, or other public health information authored or
co-authored by CDC or funded partners.
As a repository, CDC STACKS retains documents in their original published format to ensure public access to scientific information.
As a repository, CDC STACKS retains documents in their original published format to ensure public access to scientific information.
You May Also Like